|Articles|October 4, 2019

Spain's Almirall Launches Dermatology Digital Health Initiative

Almirall (Barcelona, Spain) has launched its first call for innovation to start-ups focused on dermatology digital health.   The Almirall initiative is part of an accelerator program (the Digital Garden) to strengthen the company’s commitment to digital innovation. The winning five start-ups will be announced on November 14 at the Frontiers Health 2019 event in Berlin, Germany.   The winning project teams will begin a nine-month acceleration program in January 2020 at the Barcelona Health Hub headquarters, with the objective of securing venture capital funding. In addition, the start-ups will receive up to €50K in grants, mentoring from pharma industry experts, and the opportunity to leverage leading hospitals in Barcelona as "test beds" for digital pilots.   Companies can apply at almiralldigitalgarden.com   almirall.com  


Related to this article

Pharmaceutical Executive Daily
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.